Early detection of cancer: past, present, and future
Screening in both healthy and high-risk populations offers the opportunity to detect cancer
early and with an increased opportunity for treatment and curative intent. Currently, a …
early and with an increased opportunity for treatment and curative intent. Currently, a …
Hereditary breast cancer: syndromes, tumour pathology and molecular testing
A Sokolova, KJ Johnstone, AE McCart Reed… - …, 2023 - Wiley Online Library
Hereditary factors account for a significant proportion of breast cancer risk. Approximately
20% of hereditary breast cancers are attributable to pathogenic variants in the highly …
20% of hereditary breast cancers are attributable to pathogenic variants in the highly …
[PDF][PDF] 中国女性乳腺癌筛查与早诊早治指南(2021, 北京)
赫捷， 陈万青， 李霓， 沈洪兵， 李江， 王勇， 李静… - 中国 …, 2021 - medi-guide.meditool.cn
乳腺癌是中国女性最常见的恶性肿瘤, 发病率位居中国女性恶性肿瘤首位. 国家癌症中心受国家
卫生健康委员会疾病预防控制局委托, 根据《 世界卫生组织指南制定手册》 …
卫生健康委员会疾病预防控制局委托, 根据《 世界卫生组织指南制定手册》 …
Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and …
CC Riedl, N Luft, C Bernhart, M Weber… - Journal of clinical …, 2015 - ascopubs.org
Purpose To evaluate the breast cancer screening efficacy of mammography, ultrasound, and
magnetic resonance imaging (MRI) in a high-risk population and in various population …
magnetic resonance imaging (MRI) in a high-risk population and in various population …
Li-Fraumeni syndrome: cancer risk assessment and clinical management
KA McBride, ML Ballinger, E Killick, J Kirk… - Nature reviews Clinical …, 2014 - nature.com
Carriers of germline mutations in the TP53 gene, encoding the cell-cycle regulator and
tumour suppressor p53, have a markedly increased risk of cancer-related morbidity and …
tumour suppressor p53, have a markedly increased risk of cancer-related morbidity and …
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: updated evidence report and systematic review for the US Preventive …
Importance Pathogenic mutations in breast cancer susceptibility
genesBRCA1andBRCA2increase risks for breast, ovarian, fallopian tube, and peritoneal …
genesBRCA1andBRCA2increase risks for breast, ovarian, fallopian tube, and peritoneal …
High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer
U Bick, C Engel, B Krug, W Heindel… - Breast cancer research …, 2019 - Springer
Purpose To report on 10 years of high-risk service screening with annual MRI in the German
Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC). Methods A cohort of …
Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC). Methods A cohort of …
Long-term results of screening with magnetic resonance imaging in women with BRCA mutations
K Passaperuma, E Warner, PA Causer, KA Hill… - British journal of …, 2012 - nature.com
Background: The addition of breast magnetic resonance imaging (MRI) to screening
mammography for women with BRCA mutations significantly increases sensitivity, but there …
mammography for women with BRCA mutations significantly increases sensitivity, but there …
Comparison of screening CEDM and MRI for women at increased risk for breast cancer: a pilot study
MS Jochelson, K Pinker, DD Dershaw… - European journal of …, 2017 - Elsevier
Objectives Contrast enhanced digital mammography (CEDM) is a new breast imaging
technology increasingly used in the diagnostic setting but its utility in the pure screening …
technology increasingly used in the diagnostic setting but its utility in the pure screening …
MRI breast screening in high-risk women: cancer detection and survival analysis
ED Gareth, K Nisha, L Yit, G Soujanye, H Emma… - Breast cancer research …, 2014 - Springer
Women with a genetic predisposition to breast cancer tend to develop the disease at a
younger age with denser breasts making mammography screening less effective. The …
younger age with denser breasts making mammography screening less effective. The …